We want to make sure you have access to everything you need. This week’s Q&A takes a look at how to see all of our recommendations. We also take a look at which companies to buy in a merger and some troubling corporate policies. Read on…
I want to make sure I personally am doing everything I can to keep all of our members happy.
That’s why I was concerned when I received a particular message. One of our new members, Phil M., told me he was proud to become a part of the National Institute for Cannabis Investors family, but that his feelings quickly soured.
I’m going to start our weekly member Q&A today by addressing Phil’s concerns, and I hope that in doing so, I’ll ensure that none of our fellow members experience the same frustration.
Phil M. writes: “I wear my NICI badge on my shirt collar and gladly answer any questions that it prompts. However I just removed it as I have never received the stock recommendations that I believe were promised to new joiners.”
Hello, Phil, and welcome to NICI. I’m sorry you had a bad experience upon joining. We try really hard to bring new members up to date as quickly as possible, and the picks you were promised should have been in the first email you received. But I know that sometimes our messages get lost in the huge pile of other emails that make their way into all of your inboxes these days.
Happily, the emails are not the only ways to get access to our picks. On the NICI website, make sure you’re signed in and hit the big yellow button on the right that says “Dashboard.” Then, on the page for Cannabis Investor’s Report, you’ll see a link to our model portfolio. Click that, and all of our current recommendations will be right there for you.
If you did also sign up for The Cannabis IPO Insider, you can find all of our recommendations for that service by clicking on its logo on the Dashboard page, where you’ll find a link to the Insider‘s portfolio.
We list our portfolios in alphabetical order, but if you want to see our latest picks, click on the “open date” link on top of the list twice. That will order the picks from newest to oldest.
I hope this helps you out and that you’ll feel proud to put that badge back on! If you do still have any questions, we have an outstanding Customer Support team who are happy to help you at a moment’s notice. You can reach them by phone at 866-260-0361, or by email at firstname.lastname@example.org.
Our next question involves how investors should handle mergers and acquisitions.
Joe D. says: “I have stocks in Cresco and Harvest Health and Recreation. Do I still have to buy stocks in Origin House and Verano Holdings, or am I alright with the two that I already have? Thank you for your help.”
Joe, you absolutely don’t have to add Origin House (CSE: OH, OTC: ORHOF) or Verano. In fact, you can’t add Verano, because it’s a private company! Similarly, Origin House holders need not add Cresco Labs (CSE: CL, OTC: CRLBF) stock – if they wait long enough, the shares will change to Cresco on their own.
However, some investors may want to buy some additional shares because both companies will be larger after their acquisitions close, and some investors feel more comfortable having more money invested in larger companies and less money in smaller companies.
It’s all up to you and your investment objectives. But if you just want to be sure that you have some exposure to both combined companies, you’ve already done everything you need to do.
Our final question today is about a tricky subject: drug testing.
Laura C. writes: “Recently, the corporation my husband works for required all of its employees at a work site in a legal cannabis use state to undergo medical testing for evidence of illegal substances in their bodies. One hundred and fifty employees tested positive and were fired. This was in response to work related issues and the federal government’s decision. How will our country deal with this issue?”
Laura, great question. I’m sad to report that our country will deal with the issue of cannabis in the workplace slowly – and not all that well – for at least a little while. Just this week, The National Law Review published a cautionary article for employers on the subject of cannabis testing in a world where it is increasingly legal. Some industries are required by federal law to test some employees for cannabis – the trucking industry is an example. Not much of that will change until the federal government takes THC off of Schedule 1 of the Controlled Substances Act.
Outside of federal regulation, state and local regulations are starting to change in favor of those employees who choose cannabis for medication or in their private lives. New York City just banned pre-employment testing for cannabis for most jobs. In New Jersey and Connecticut, courts have ruled that an employer may not discriminate against job applicants who test positive for cannabis if they are medical patients (who are the only legal users in those states). And some employers are dropping cannabis testing altogether, in part because it’s difficult to find good workers in this economy.
But even with that progress, workers remain at risk in many places. Eventually, voters on the one hand and employers seeking qualified applicants on the other will change cannabis testing rules.
As those developments happen – and as the normalization of cannabis progresses across North America and indeed the rest of the world – the markets are going to take off.
The Institute is tracking these events closely, and we’ll make sure you know how to make the biggest profits during this monumental shift.
I hope you’ll be there for the ride.
Executive Director, National Institute for Cannabis Investors
P.S. Just yesterday, the FDA held its first-ever public hearing on CBD, the purpose of which was to allow “stakeholders an opportunity to provide the FDA with additional input” on the substance. This marks the beginning of big movements in CBD regulation, and we’ll have more information on the hearing early next week. Make sure you’re on the lookout for it!
One response to “Q&A: When Will We Fix Drug Tests?”
June 01 2019